Direkt zum Inhalt
Fachrepositorium Lebenswissenschaften
Freier Zugang zu Wissensressourcen aus den Lebenswissenschaften
Suche
Publisso-Menue
Publizieren
PUBLISSO-System
Bücher
Policy Bücher
Bücher Übersicht
Zeitschriften / Artikel
Journals Übersicht
Serien
Policy Serien
MAK Collection
Kongresse
Forschungsdaten
Repositorien
Fachrepositorium Lebenswissenschaften
Publizieren im Fachrepositorium
LeibnizOpen
Beraten
Forschungsdatenmanagement
Digitale Langzeitarchivierung
Wir für Sie
Volltexte
Filter (Auswahl)
Male [MeSH]
[x]
Carcinoma, Non-Small-Cell Lung/therapy [MeSH]
[x]
Sacherschließung
Lung Neoplasms/therapy [MeSH]
(5)
Neoplasm Staging [MeSH]
(4)
Middle Aged [MeSH]
(4)
Humans [MeSH]
(4)
Female [MeSH]
(4)
Retrospective Studies [MeSH]
(3)
NSCLC
(2)
Lung Neoplasms/pathology [MeSH]
(2)
Publikationstyp
Artikel
(6)
Medium
Erscheinungsjahr
2024
(2)
2023
(1)
2021
(3)
Institution
6 Treffer
Kurzansicht
E-Jahr
Zugriff
Typ
Operations
Effect of TTF-1 expression on progression free survival of immunotherapy and chemo-/immunotherapy in patients with non-small cell lung cancer
2024 .
Uhlenbruch, Mark
|
Krüger, Stefan
2024
http://purl.org/ontology/bibo/Article
Prognostic value of metabolic tumor volume on [18F]FDG PET/CT in addition to the TNM classification system of locally advanced non-small cell lung cancer
2024 .
Brose, Alexander
|
Miederer, Isabelle
|
König, Jochem
|
Gkika, Eleni
|
Sahlmann, Jörg
|
Schimek-Jasch, Tanja
|
Schreckenberger, Mathias
|
Nestle, Ursula
|
Kappes, Jutta
|
Miederer, Matthias
2024
http://purl.org/ontology/bibo/Article
First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis
2023 .
Hofstetter, Kerstin
|
Taugner, Julian
|
Käsmann, Lukas
|
Mansoorian, Sina
|
Flörsch, Benedikt
|
Eze, Chukwuka
|
Tufman, Amanda
|
Reinmuth, Niels
|
Duell, Thomas
|
Belka, Claus
|
Manapov, Farkhad
2023
http://purl.org/ontology/bibo/Article
Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition
2021 .
Unterrainer, Marcus
|
Taugner, Julian
|
Käsmann, Lukas
|
Tufman, Amanda
|
Reinmuth, Niels
|
Li, Minglun
|
Mittlmeier, Lena M.
|
Bartenstein, Peter
|
Kunz, Wolfgang G.
|
Ricke, Jens
|
Belka, Claus
|
Eze, Chukwuka
|
Manapov, Farkhad
2021
http://purl.org/ontology/bibo/Article
Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition
2021 .
Taugner, Julian
|
Käsmann, Lukas
|
Karin, Monika
|
Eze, Chukwuka
|
Flörsch, Benedikt
|
Guggenberger, Julian
|
Li, Minglun
|
Tufman, Amanda
|
Reinmuth, Niels
|
Duell, Thomas
|
Belka, Claus
|
Manapov, Farkhad
2021
http://purl.org/ontology/bibo/Article
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients
2021 .
Taugner, Julian
|
Käsmann, Lukas
|
Eze, Chukwuka
|
Rühle, Alexander
|
Tufman, Amanda
|
Reinmuth, Niels
|
Duell, Thomas
|
Belka, Claus
|
Manapov, Farkhad
2021
http://purl.org/ontology/bibo/Article
